Fulnite (Eszopiclone)

Fulnite (Eszopiclone): Patient Information Leaflet – Australia

1. Basic Product Information

2. Mechanism of Action

For Patients: Eszopiclone belongs to a group of medicines called hypnotics. It acts on the brain to help you fall asleep faster, stay asleep longer, and reduce the number of times you wake during the night. In simple terms, it calms brain activity to help with insomnia.

For Health Professionals: Eszopiclone is a non-benzodiazepine hypnotic that modulates the gamma-aminobutyric acid (GABA-A) receptor complex via the benzodiazepine binding site. It selectively binds to the omega-1 (BZ1) subtype, enhancing inhibitory neurotransmission and yielding sedative, anxiolytic, and muscle relaxant effects with minimal anticonvulsant activity.

3. Pharmacokinetics

• Absorption: Rapid oral absorption. Peak plasma concentration (T_max) occurs about 1 hour after ingestion.
• Metabolism: Extensively metabolised in the liver by CYP3A4 and CYP2E1 isoenzymes into inactive metabolites.
• Elimination: Excreted largely as metabolites via urine; less than 10% excreted unchanged.
• Duration of action: Elimination half-life approximately 6 hours (varies by age and liver function).

4. Use in Everyday Life and Best Practices

Eszopiclone is commonly prescribed for short-term treatment of insomnia, particularly where difficulty falling or staying asleep affects daytime functioning. In Australia, it is typically taken shortly before going to bed, and only when a full 7–8 hours of sleep is possible.

• Take exactly as prescribed by your doctor – usually 1 mg initially, potentially increased to 2 mg or 3 mg based on your needs and response.
• Swallow tablet whole with water. Do not crush or chew.
• Not recommended for use longer than 2–4 weeks without GP review.
• Keep tablets in original packaging, below 25℃; do not share with others.

5. Dosing in the Morning vs Evening

• Evening dosing: Eszopiclone should always be taken at bedtime, not during waking hours, due to sedative effects and risk of impaired alertness.
• Dosing in the morning: Strongly discouraged. Taking in the morning can cause daytime drowsiness, impaired driving, and memory disturbance.
• Key Tip: For best effect and least side effects, take just before lying down in bed.

6. Taking with Food or on an Empty Stomach

Food, especially high-fat meals, can delay the onset of sleep effects by up to 1 hour but does not reduce the total absorption of Eszopiclone. For optimal effect, take Eszopiclone on an empty stomach, ideally 30 minutes after dinner but before bedtime. Traditional English diets featuring late-evening tea, desserts, or snacks may impact medicine onset – so avoid heavy meals close to your dose.

7. Interaction Warnings

8. Indications

9. Dosing According to Clinical Indication

10. Safety Profile & Side Effects

Warnings: Risk of next-day impairment, especially if you do not get enough sleep. Never combine with alcohol or other sedative medications unless advised. Do not drive, operate machinery, or perform dangerous tasks after taking Eszopiclone or the next morning if you feel drowsy.

11. Guidelines for Proper Use in Australia

• Use Eszopiclone only as a short-term aid for sleep and not as a long-term solution.
• Discuss with your GP or pharmacist if you have a history of depression, substance use disorder, breathing problems, or liver disease.
• Avoid sudden discontinuation after regular use—dose reduction (“taper”) recommended.
• Do not increase dose or frequency without consulting your healthcare provider.
• Combine with non-drug treatments: sleep hygiene, cognitive-behavioural therapy for insomnia (CBT-I), lifestyle adjustments as recommended by Sleep Health Foundation Australia.
• Store securely, out of reach of children and others.
• Return any unused tablets to your local pharmacy for safe disposal – don’t flush or bin.

12. Alternative Treatment Options

• Zolpidem (Stilnox, generic): A related “Z-drug” with similar efficacy; shorter duration, less metallic taste, possible sleep behaviour disturbances.
• Temazepam (Normison): A benzodiazepine hypnotic; sedative effects last longer, higher dependence risk.
• Melatonin: For delayed sleep phase or circadian rhythm disorders, available on prescription; lower dependence risk, fewer side effects.
• Cognitive Behavioural Therapy for Insomnia (CBT-I): First-line therapy, non-medication, highest evidence for long-term benefits, widely offered via referral in Australia’s public and private systems.
• Doxylamine, Diphenhydramine (over-the-counter antihistamines): Short-term utility, increased risk of morning drowsiness and confusion, especially in elderly.

Pros & Cons Overview:
- Eszopiclone: Effective for sleep maintenance, short-term use only, metallic taste
- Melatonin: Very safe, mild efficacy, best for circadian issues
- CBT-I: Most effective long-term, no drug risks, slower onset of benefit

13. Legal, Registration, and Reimbursement Status in Australia

• Registered with the Therapeutic Goods Administration (TGA) as a Schedule 4 prescription medicine
• Not subsidised by the Pharmaceutical Benefits Scheme (PBS) for primary insomnia; private script required
• Doctors must comply with state-level controlled substance prescribing rules
• Pharmacists check for drug interactions and provide counselling at dispensing
• It is illegal to drive or undertake safety-sensitive work if impaired by sedative medicines like Eszopiclone

14. Latest Research and Clinical Guidance (2022–2025)

• Royal Australasian College of Physicians (RACP) and Sleep Health Foundation (2023): Recommends sedative hypnotics as a last resort after CBT-I and sleep hygiene. Use lowest effective dose for shortest duration.
• Cochrane Review (2022): Eszopiclone improves sleep onset and duration modestly; most benefit in short-term use (<4 weeks); risk of dependence with prolonged use.
• Australian Prescriber (2024): “Prescribe with caution in elderly and those with history of substance misuse. Monitor for next-day impairment and adverse sleep behaviours.” (see sources NPS MedicineWise).

For further information, see the “Sleep Disorders” guideline from the Australian Department of Health or the Sleep Health Foundation.

15. Availability and Delivery (Australia)

*Delivery times can vary by stock availability and courier service. Prescription required for all sales.

16. Frequently Asked Questions (FAQ)

1. How long does Eszopiclone take to work?
   Most people start to feel sleepy within 30–60 minutes after taking Eszopiclone. If taken with food, especially a large or fatty meal, the onset may be delayed.
2. Is Eszopiclone addictive?
   Eszopiclone can be habit-forming, especially if used long-term or in higher-than-recommended doses. Use only as directed by your doctor and discuss any concerns about dependence.
3. Can I drive or work the next day after taking Eszopiclone?
   Never drive or operate machinery if you feel drowsy the next morning. Some people experience next-day impairment, especially if not allowing 7–8 hours for sleep or if taking higher doses.
4. What should I do if I miss a dose?
   Skip the missed dose. Do not take Eszopiclone unless you have time for a full night’s sleep. Never double dose to “catch up.”
5. Are there any foods or drinks to avoid?
   Avoid alcohol and limit grapefruit juice, as both can increase side effects. It is best to take Eszopiclone on an empty stomach for rapid sleep onset.

References

• Therapeutic Goods Administration (TGA) Scheduling
• Sleep Health Foundation Australia
• NPS MedicineWise
• Cochrane Review: Eszopiclone for Insomnia (2022)
• Australian Prescriber. (2024). “Sedative Hypnotics for Insomnia”